Market Research Logo

Global Pancreatic Beta-Cell Protection Market Analysis 2016 - Forecast to 2022

Global Pancreatic Beta-Cell Protection Market Analysis 2016 - Forecast to 2022

Hoovers Research analysis is one of the most accurate studies performed using the combinational analytical tools. The report contains up to date financial data derived from varied research sources to present unique and reliable analysis. Assessment of major trends with potential impact on the market during the next five years, including a deep dive analysis of market segmentation which comprises of sub markets, regional and country level analysis. The report provides a comprehensive outlook about the market share along with strategic recommendations based on the emerging segments.

This report analyzes the global markets for "Pancreatic Beta-Cell Protection". The market assessment is performed through standard and the tailored research methodology approach. The market overview offers in depth analysis at the regional and country level, for instance North America (U.S., Canada and Mexico), Europe (Germany, France, Italy, U.K. and Spain), Asia-Pacific (China, Japan, India, Australia, South Korea and Rest of APAC) and Rest of the World (Middle East, Africa and Latin America). Annual estimations and forecasts are provided from the year 2013 to 2022 for each given segment and sub segments. Market data derived from the authenticated and reliable sources is subjected to validation from the industry experts. The report also analyzes the market by discussing market dynamics such as drivers, constraints, opportunities, threats, challenges and other market trends. Competitive landscaping provides the recent activities performed by the active players in the market. Activities such as product launch, agreements, joint ventures, partnerships, acquisitions and mergers, and other activities.

This report provides:

  • Market Sizing estimations and forecasts for a minimum of 6 years of all the given segments, sub segments and the regional markets
  • Identifying market dynamics (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
  • Strategic recommendations in key business segments based on the market estimations
  • Regional and country level market analysis
  • Competitive landscaping mapping the key common trends
  • Company profiling covering the financials, recent activities and the future strategies
  • Supply chain trends mapping the recent advancements
  • Strategic recommendations for the new entrants


1 Introduction
1.1 Scope of the Report
1.2 Report Description
1.3 Research Methodology
1.4 Research Sources
1.4.1 Secondary Research
1.4.2 Primary Research
1.4.3 Assumptions
1.5 List of Abbreviations
2 Executive Summary
3 Market Analysis
3.1 Market Segmentation
3.2 Market Size Estimation
3.3 Market Drivers
3.4 Market Constraints
3.5 Pipeline Analysis
4 Porters Five Force Analysis
4.1 Bargaining power of suppliers
4.2 Bargaining power of buyers
4.3 Threat of substitutes
4.4 Threat of new entrants
4.5 Competitive rivalry
5 Pancreatic Beta-Cell Protection Market by Therapy
5.1 Introduction
5.2 Stem Cell Based
5.3 Gene Therapies
5.4 RNA Based therapies
5.5 Monoclonal Antibodies (MAbs)
5.6 Phytotherapy
6 Pancreatic Beta-Cell Protection Market by Molecule
6.1 Introduction
6.2 Small Molecules
6.3 Large Molecules
7 Pancreatic Beta-Cell Protection Market by Disorder
7.1 Introduction
7.2 Type-1 diabetes
7.3 Type-2 diabetes
8 Pancreatic Beta-Cell Protection Market by Target
8.1 Introduction
8.2 Beta Cell Apoptosis
8.3 Other Targets
9 Geographical Segmentation
9.1 North America
9.1.1 US
9.1.2 Canada
9.1.3 Mexico
9.2 Europe
9.2.1 Germany
9.2.2 France
9.2.3 Italy
9.2.4 UK
9.2.5 Spain
9.3 Asia Pacific
9.3.1 Japan
9.3.2 China
9.3.3 India
9.3.4 Australia
9.3.5 New Zealand
9.3.6 Rest of Asia Pacific
9.4 RoW
9.4.1 Latin America
9.4.2 Middle East
9.4.3 Africa
9.4.4 Others
10 Vendor Landscaping
10.1 Agreements, Partnerships, Collaborations and Joint Ventures
10.2 Acquisitions & Mergers
10.3 New Product Launch
10.4 Expansions
10.5 Other Key Strategies
11 Company Profiles
11.1 ViaCyte Inc
11.1.1 Business Overview
11.1.2 SWOT Analysis
11.1.3 Financial Overview
11.1.4 Strategy
11.1.5 Key Activities
11.2 PharmaCyte Biotech Inc
11.3 Boehringer Ingelheim
11.4 GalaxoSmithKline
11.5 Beta-Cell NV
11.6 Novartis
11.7 Janssen Research & Development
11.8 Pfizer Inc
11.9 BioLineRx
11.10 Genentech
11.11 Novo Nordisk
11.12 Sanofi
11.13 Osiris Therapeutics
11.14 Beta-O2 Technologies Ltd
11.15 Transition Therapeutics
11.16 Bayhill Therapeutics
11.17 Merck & Co
11.18 Takeda Pharmaceuticals
11.19 Connexios Life Systems
11.20 Eli Lilly and Company
12 Appendix
13 Disclaimer
List of Tables
Table 1 Global Pancreatic Beta-Cell Protection Market Analysis, by Region, 2013-2022 ($MN)
Table 2 Global Pancreatic Beta-Cell Protection Market Analysis, by Therapies, 2013-2022 ($MN)
Table 3 Global Stem Cell Based Market Analysis, by Region, 2013-2022 ($MN)
Table 4 Global Stem Cell Based Market Analysis, by Molecule, 2013-2022 ($MN)
Table 5 Global Stem Cell Based Market Analysis, by Disorder, 2013-2022 ($MN)
Table 6 Global Stem Cell Based Market Analysis, by Target, 2013-2022 ($MN)
Table 7 Global Gene Therapies Based Market Analysis, by Region, 2013-2022 ($MN)
Table 8 Global Gene Therapies Based Market Analysis, by Molecule, 2013-2022 ($MN)
Table 9 Global Gene Therapies Based Market Analysis, by Disorder, 2013-2022 ($MN)
Table 10 Global Gene Therapies Based Market Analysis, by Target, 2013-2022 ($MN)
Table 11 Global RNA Based Therapies Based Market Analysis, by Region, 2013-2022 ($MN)
Table 12 Global RNA Based Therapies Based Market Analysis, by Molecule, 2013-2022 ($MN)
Table 13 Global RNA Based Therapies Based Market Analysis, by Disorder, 2013-2022 ($MN)
Table 14 Global RNA Based Therapies Based Market Analysis, by Target, 2013-2022 ($MN)
Table 15 Global Monoclonal Antibodies (MAbs) Market Analysis, by Region, 2013-2022 ($MN)
Table 16 Global Monoclonal Antibodies (MAbs) Market Analysis, by Molecule, 2013-2022 ($MN)
Table 17 Global Monoclonal Antibodies (MAbs) Market Analysis, by Disorder, 2013-2022 ($MN)
Table 18 Global Monoclonal Antibodies (MAbs) Market Analysis, by Target, 2013-2022 ($MN)
Table 19 Global Phytotherapy Based Market Analysis, by Region, 2013-2022 ($MN)
Table 20 Global Phytotherapy Based Market Analysis, by Molecule, 2013-2022 ($MN)
Table 21 Global Phytotherapy Based Market Analysis, by Disorder, 2013-2022 ($MN)
Table 22 Global Phytotherapy Based Market Analysis, by Target, 2013-2022 ($MN)
Table 23 Global Pancreatic Beta-Cell Protection Market Analysis, by Molecule, 2013-2022 ($MN)
Table 24 Global Small Molecules Market Analysis, by Region, 2013-2022 ($MN)
Table 25 Global Small Molecules Market Analysis, by Therapy, 2013-2022 ($MN)
Table 26 Global Small Molecules Market Analysis, by Disorder, 2013-2022 ($MN)
Table 27 Global Small Molecules Market Analysis, by Target, 2013-2022 ($MN)
Table 28 Global Large Molecules Market Analysis, by Region, 2013-2022 ($MN)
Table 29 Global Large Molecules Market Analysis, by Therapy, 2013-2022 ($MN)
Table 30 Global Large Molecules Market Analysis, by Disorder, 2013-2022 ($MN)
Table 31 Global Large Molecules Market Analysis, by Target, 2013-2022 ($MN)
Table 32 Global Pancreatic Beta-Cell Protection Market Analysis, by Disorder, 2013-2022 ($MN)
Table 33 Global Type-1 diabetes Market Analysis, by Region, 2013-2022 ($MN)
Table 34 Global Type-1 diabetes Market Analysis, by Therapy, 2013-2022 ($MN)
Table 35 Global Type-1 diabetes Market Analysis, by Molecule, 2013-2022 ($MN)
Table 36 Global Type-1 diabetes Market Analysis, by Target, 2013-2022 ($MN)
Table 37 Global Type-2 diabetes Market Analysis, by Region, 2013-2022 ($MN)
Table 38 Global Type-2 diabetes Market Analysis, by Therapy, 2013-2022 ($MN)
Table 39 Global Type-2 diabetes Market Analysis, by Molecule, 2013-2022 ($MN)
Table 40 Global Type-2 diabetes Market Analysis, by Target, 2013-2022 ($MN)
Table 41 Global Pancreatic Beta-Cell Protection Market Analysis, by Target, 2013-2022 ($MN)
Table 42 Global Beta Cell Apoptosis Market Analysis, by Region, 2013-2022 ($MN)
Table 43 Global Beta Cell Apoptosis Market Analysis, by Therapy, 2013-2022 ($MN)
Table 44 Global Beta Cell Apoptosis Market Analysis, by Molecule, 2013-2022 ($MN)
Table 45 Global Beta Cell Apoptosis Market Analysis, by Disorder, 2013-2022 ($MN)
Table 46 Global Other Targets Market Analysis, by Region, 2013-2022 ($MN)
Table 47 Global Other Targets Market Analysis, by Therapy, 2013-2022 ($MN)
Table 48 Global Other Targets Market Analysis, by Molecule, 2013-2022 ($MN)
Table 49 Global Other Targets Market Analysis, by Disorder, 2013-2022 ($MN)
Table 50 North America Pancreatic Beta-Cell Protection Market Analysis, by Country, 2013-2022 ($MN)
Table 51 North America Pancreatic Beta-Cell Protection Market Analysis, by Therapies, 2013-2022 ($MN)
Table 52 North America Stem Cell Based Market Analysis, by Country, 2013-2022 ($MN)
Table 53 North America Stem Cell Based Market Analysis, by Molecule, 2013-2022 ($MN)
Table 54 North America Stem Cell Based Market Analysis, by Disorder, 2013-2022 ($MN)
Table 55 North America Stem Cell Based Market Analysis, by Target, 2013-2022 ($MN)
Table 56 North America Gene Therapies Based Market Analysis, by Country, 2013-2022 ($MN)
Table 57 North America Gene Therapies Based Market Analysis, by Molecule, 2013-2022 ($MN)
Table 58 North America Gene Therapies Based Market Analysis, by Disorder, 2013-2022 ($MN)
Table 59 North America Gene Therapies Based Market Analysis, by Target, 2013-2022 ($MN)
Table 60 North America RNA Based Therapies Based Market Analysis, by Country, 2013-2022 ($MN)
Table 61 North America RNA Based Therapies Based Market Analysis, by Molecule, 2013-2022 ($MN)
Table 62 North America RNA Based Therapies Based Market Analysis, by Disorder, 2013-2022 ($MN)
Table 63 North America RNA Based Therapies Based Market Analysis, by Target, 2013-2022 ($MN)
Table 64 North America Monoclonal Antibodies (MAbs) Market Analysis, by Country, 2013-2022 ($MN)
Table 65 North America Monoclonal Antibodies (MAbs) Market Analysis, by Molecule, 2013-2022 ($MN)
Table 66 North America Monoclonal Antibodies (MAbs) Market Analysis, by Disorder, 2013-2022 ($MN)
Table 67 North America Monoclonal Antibodies (MAbs) Market Analysis, by Target, 2013-2022 ($MN)
Table 68 North America Phytotherapy Based Market Analysis, by Country, 2013-2022 ($MN)
Table 69 North America Phytotherapy Based Market Analysis, by Molecule, 2013-2022 ($MN)
Table 70 North America Phytotherapy Based Market Analysis, by Disorder, 2013-2022 ($MN)
Table 71 North America Phytotherapy Based Market Analysis, by Target, 2013-2022 ($MN)
Table 72 North America Pancreatic Beta-Cell Protection Market Analysis, by Molecule, 2013-2022 ($MN)
Table 73 North America Small Molecules Market Analysis, by Country, 2013-2022 ($MN)
Table 74 North America Small Molecules Market Analysis, by Therapy, 2013-2022 ($MN)
Table 75 North America Small Molecules Market Analysis, by Disorder, 2013-2022 ($MN)
Table 76 North America Small Molecules Market Analysis, by Target, 2013-2022 ($MN)
Table 77 North America Large Molecules Market Analysis, by Country, 2013-2022 ($MN)
Table 78 North America Large Molecules Market Analysis, by Therapy, 2013-2022 ($MN)
Table 79 North America Large Molecules Market Analysis, by Disorder, 2013-2022 ($MN)
Table 80 North America Large Molecules Market Analysis, by Target, 2013-2022 ($MN)
Table 81 North America Pancreatic Beta-Cell Protection Market Analysis, by Disorder, 2013-2022 ($MN)
Table 82 North America Type-1 diabetes Market Analysis, by Country, 2013-2022 ($MN)
Table 83 North America Type-1 diabetes Market Analysis, by Therapy, 2013-2022 ($MN)
Table 84 North America Type-1 diabetes Market Analysis, by Molecule, 2013-2022 ($MN)
Table 85 North America Type-1 diabetes Market Analysis, by Target, 2013-2022 ($MN)
Table 86 North America Type-2 diabetes Market Analysis, by Country, 2013-2022 ($MN)
Table 87 North America Type-2 diabetes Market Analysis, by Therapy, 2013-2022 ($MN)
Table 88 North America Type-2 diabetes Market Analysis, by Molecule, 2013-2022 ($MN)
Table 89 North America Type-2 diabetes Market Analysis, by Target, 2013-2022 ($MN)
Table 90 North America Pancreatic Beta-Cell Protection Market Analysis, by Target, 2013-2022 ($MN)
Table 91 North America Beta Cell Apoptosis Market Analysis, by Country, 2013-2022 ($MN)
Table 92 North America Beta Cell Apoptosis Market Analysis, by Therapy, 2013-2022 ($MN)
Table 93 North America Beta Cell Apoptosis Market Analysis, by Molecule, 2013-2022 ($MN)
Table 94 North America Beta Cell Apoptosis Market Analysis, by Disorder, 2013-2022 ($MN)
Table 95 North America Other Targets Market Analysis, by Country, 2013-2022 ($MN)
Table 96 North America Other Targets Market Analysis, by Therapy, 2013-2022 ($MN)
Table 97 North America Other Targets Market Analysis, by Molecule, 2013-2022 ($MN)
Table 98 North America Other Targets Market Analysis, by Disorder, 2013-2022 ($MN)
Table 99 Europe Pancreatic Beta-Cell Protection Market Analysis, by Country, 2013-2022 ($MN)
Table 100 Europe Pancreatic Beta-Cell Protection Market Analysis, by Therapies, 2013-2022 ($MN)
Table 101 Europe Stem Cell Based Market Analysis, by Country, 2013-2022 ($MN)
Table 102 Europe Stem Cell Based Market Analysis, by Molecule, 2013-2022 ($MN)
Table 103 Europe Stem Cell Based Market Analysis, by Disorder, 2013-2022 ($MN)
Table 104 Europe Stem Cell Based Market Analysis, by Target, 2013-2022 ($MN)
Table 105 Europe Gene Therapies Based Market Analysis, by Country, 2013-2022 ($MN)
Table 106 Europe Gene Therapies Based Market Analysis, by Molecule, 2013-2022 ($MN)
Table 107 Europe Gene Therapies Based Market Analysis, by Disorder, 2013-2022 ($MN)
Table 108 Europe Gene Therapies Based Market Analysis, by Target, 2013-2022 ($MN)
Table 109 Europe RNA Based Therapies Based Market Analysis, by Country, 2013-2022 ($MN)
Table 110 Europe RNA Based Therapies Based Market Analysis, by Molecule, 2013-2022 ($MN)
Table 111 Europe RNA Based Therapies Based Market Analysis, by Disorder, 2013-2022 ($MN)
Table 112 Europe RNA Based Therapies Based Market Analysis, by Target, 2013-2022 ($MN)
Table 113 Europe Monoclonal Antibodies (MAbs) Market Analysis, by Country, 2013-2022 ($MN)
Table 114 Europe Monoclonal Antibodies (MAbs) Market Analysis, by Molecule, 2013-2022 ($MN)
Table 115 Europe Monoclonal Antibodies (MAbs) Market Analysis, by Disorder, 2013-2022 ($MN)
Table 116 Europe Monoclonal Antibodies (MAbs) Market Analysis, by Target, 2013-2022 ($MN)
Table 117 Europe Phytotherapy Based Market Analysis, by Country, 2013-2022 ($MN)
Table 118 Europe Phytotherapy Based Market Analysis, by Molecule, 2013-2022 ($MN)
Table 119 Europe Phytotherapy Based Market Analysis, by Disorder, 2013-2022 ($MN)
Table 120 Europe Phytotherapy Based Market Analysis, by Target, 2013-2022 ($MN)
Table 121 Europe Pancreatic Beta-Cell Protection Market Analysis, by Molecule, 2013-2022 ($MN)
Table 122 Europe Small Molecules Market Analysis, by Country, 2013-2022 ($MN)
Table 123 Europe Small Molecules Market Analysis, by Therapy, 2013-2022 ($MN)
Table 124 Europe Small Molecules Market Analysis, by Disorder, 2013-2022 ($MN)
Table 125 Europe Small Molecules Market Analysis, by Target, 2013-2022 ($MN)
Table 126 Europe Large Molecules Market Analysis, by Country, 2013-2022 ($MN)
Table 127 Europe Large Molecules Market Analysis, by Therapy, 2013-2022 ($MN)
Table 128 Europe Large Molecules Market Analysis, by Disorder, 2013-2022 ($MN)
Table 129 Europe Large Molecules Market Analysis, by Target, 2013-2022 ($MN)
Table 130 Europe Pancreatic Beta-Cell Protection Market Analysis, by Disorder, 2013-2022 ($MN)
Table 131 Europe Type-1 diabetes Market Analysis, by Country, 2013-2022 ($MN)
Table 132 Europe Type-1 diabetes Market Analysis, by Therapy, 2013-2022 ($MN)
Table 133 Europe Type-1 diabetes Market Analysis, by Molecule, 2013-2022 ($MN)
Table 134 Europe Type-1 diabetes Market Analysis, by Target, 2013-2022 ($MN)
Table 135 Europe Type-2 diabetes Market Analysis, by Country, 2013-2022 ($MN)
Table 136 Europe Type-2 diabetes Market Analysis, by Therapy, 2013-2022 ($MN)
Table 137 Europe Type-2 diabetes Market Analysis, by Molecule, 2013-2022 ($MN)
Table 138 Europe Type-2 diabetes Market Analysis, by Target, 2013-2022 ($MN)
Table 139 Europe Pancreatic Beta-Cell Protection Market Analysis, by Target, 2013-2022 ($MN)
Table 140 Europe Beta Cell Apoptosis Market Analysis, by Country, 2013-2022 ($MN)
Table 141 Europe Beta Cell Apoptosis Market Analysis, by Therapy, 2013-2022 ($MN)
Table 142 Europe Beta Cell Apoptosis Market Analysis, by Molecule, 2013-2022 ($MN)
Table 143 Europe Beta Cell Apoptosis Market Analysis, by Disorder, 2013-2022 ($MN)
Table 144 Europe Other Targets Market Analysis, by Country, 2013-2022 ($MN)
Table 145 Europe Other Targets Market Analysis, by Therapy, 2013-2022 ($MN)
Table 146 Europe Other Targets Market Analysis, by Molecule, 2013-2022 ($MN)
Table 147 Europe Other Targets Market Analysis, by Disorder, 2013-2022 ($MN)
Table 148 Asia Pacific Pancreatic Beta-Cell Protection Market Analysis, by Country, 2013-2022 ($MN)
Table 149 Asia Pacific Pancreatic Beta-Cell Protection Market Analysis, by Therapies, 2013-2022 ($MN)
Table 150 Asia Pacific Stem Cell Based Market Analysis, by Country, 2013-2022 ($MN)
Table 151 Asia Pacific Stem Cell Based Market Analysis, by Molecule, 2013-2022 ($MN)
Table 152 Asia Pacific Stem Cell Based Market Analysis, by Disorder, 2013-2022 ($MN)
Table 153 Asia Pacific Stem Cell Based Market Analysis, by Target, 2013-2022 ($MN)
Table 154 Asia Pacific Gene Therapies Based Market Analysis, by Country, 2013-2022 ($MN)
Table 155 Asia Pacific Gene Therapies Based Market Analysis, by Molecule, 2013-2022 ($MN)
Table 156 Asia Pacific Gene Therapies Based Market Analysis, by Disorder, 2013-2022 ($MN)
Table 157 Asia Pacific Gene Therapies Based Market Analysis, by Target, 2013-2022 ($MN)
Table 158 Asia Pacific RNA Based Therapies Based Market Analysis, by Country, 2013-2022 ($MN)
Table 159 Asia Pacific RNA Based Therapies Based Market Analysis, by Molecule, 2013-2022 ($MN)
Table 160 Asia Pacific RNA Based Therapies Based Market Analysis, by Disorder, 2013-2022 ($MN)
Table 161 Asia Pacific RNA Based Therapies Based Market Analysis, by Target, 2013-2022 ($MN)
Table 162 Asia Pacific Monoclonal Antibodies (MAbs) Market Analysis, by Country, 2013-2022 ($MN)
Table 163 Asia Pacific Monoclonal Antibodies (MAbs) Market Analysis, by Molecule, 2013-2022 ($MN)
Table 164 Asia Pacific Monoclonal Antibodies (MAbs) Market Analysis, by Disorder, 2013-2022 ($MN)
Table 165 Asia Pacific Monoclonal Antibodies (MAbs) Market Analysis, by Target, 2013-2022 ($MN)
Table 166 Asia Pacific Phytotherapy Based Market Analysis, by Country, 2013-2022 ($MN)
Table 167 Asia Pacific Phytotherapy Based Market Analysis, by Molecule, 2013-2022 ($MN)
Table 168 Asia Pacific Phytotherapy Based Market Analysis, by Disorder, 2013-2022 ($MN)
Table 169 Asia Pacific Phytotherapy Based Market Analysis, by Target, 2013-2022 ($MN)
Table 170 Asia Pacific Pancreatic Beta-Cell Protection Market Analysis, by Molecule, 2013-2022 ($MN)
Table 171 Asia Pacific Small Molecules Market Analysis, by Country, 2013-2022 ($MN)
Table 172 Asia Pacific Small Molecules Market Analysis, by Therapy, 2013-2022 ($MN)
Table 173 Asia Pacific Small Molecules Market Analysis, by Disorder, 2013-2022 ($MN)
Table 174 Asia Pacific Small Molecules Market Analysis, by Target, 2013-2022 ($MN)
Table 175 Asia Pacific Large Molecules Market Analysis, by Country, 2013-2022 ($MN)
Table 176 Asia Pacific Large Molecules Market Analysis, by Therapy, 2013-2022 ($MN)
Table 177 Asia Pacific Large Molecules Market Analysis, by Disorder, 2013-2022 ($MN)
Table 178 Asia Pacific Large Molecules Market Analysis, by Target, 2013-2022 ($MN)
Table 179 Asia Pacific Pancreatic Beta-Cell Protection Market Analysis, by Disorder, 2013-2022 ($MN)
Table 180 Asia Pacific Type-1 diabetes Market Analysis, by Country, 2013-2022 ($MN)
Table 181 Asia Pacific Type-1 diabetes Market Analysis, by Therapy, 2013-2022 ($MN)
Table 182 Asia Pacific Type-1 diabetes Market Analysis, by Molecule, 2013-2022 ($MN)
Table 183 Asia Pacific Type-1 diabetes Market Analysis, by Target, 2013-2022 ($MN)
Table 184 Asia Pacific Type-2 diabetes Market Analysis, by Country, 2013-2022 ($MN)
Table 185 Asia Pacific Type-2 diabetes Market Analysis, by Therapy, 2013-2022 ($MN)
Table 186 Asia Pacific Type-2 diabetes Market Analysis, by Molecule, 2013-2022 ($MN)
Table 187 Asia Pacific Type-2 diabetes Market Analysis, by Target, 2013-2022 ($MN)
Table 188 Asia Pacific Pancreatic Beta-Cell Protection Market Analysis, by Target, 2013-2022 ($MN)
Table 189 Asia Pacific Beta Cell Apoptosis Market Analysis, by Country, 2013-2022 ($MN)
Table 190 Asia Pacific Beta Cell Apoptosis Market Analysis, by Therapy, 2013-2022 ($MN)
Table 191 Asia Pacific Beta Cell Apoptosis Market Analysis, by Molecule, 2013-2022 ($MN)
Table 192 Asia Pacific Beta Cell Apoptosis Market Analysis, by Disorder, 2013-2022 ($MN)
Table 193 Asia Pacific Other Targets Market Analysis, by Country, 2013-2022 ($MN)
Table 194 Asia Pacific Other Targets Market Analysis, by Therapy, 2013-2022 ($MN)
Table 195 Asia Pacific Other Targets Market Analysis, by Molecule, 2013-2022 ($MN)
Table 196 Asia Pacific Other Targets Market Analysis, by Disorder, 2013-2022 ($MN)
Table 197 RoW Pancreatic Beta-Cell Protection Market Analysis, by Country, 2013-2022 ($MN)
Table 198 RoW Pancreatic Beta-Cell Protection Market Analysis, by Therapies, 2013-2022 ($MN)
Table 199 RoW Stem Cell Based Market Analysis, by Country, 2013-2022 ($MN)
Table 200 RoW Stem Cell Based Market Analysis, by Molecule, 2013-2022 ($MN)
Table 201 RoW Stem Cell Based Market Analysis, by Disorder, 2013-2022 ($MN)
Table 202 RoW Stem Cell Based Market Analysis, by Target, 2013-2022 ($MN)
Table 203 RoW Gene Therapies Based Market Analysis, by Country, 2013-2022 ($MN)
Table 204 RoW Gene Therapies Based Market Analysis, by Molecule, 2013-2022 ($MN)
Table 205 RoW Gene Therapies Based Market Analysis, by Disorder, 2013-2022 ($MN)
Table 206 RoW Gene Therapies Based Market Analysis, by Target, 2013-2022 ($MN)
Table 207 RoW RNA Based Therapies Based Market Analysis, by Country, 2013-2022 ($MN)
Table 208 RoW RNA Based Therapies Based Market Analysis, by Molecule, 2013-2022 ($MN)
Table 209 RoW RNA Based Therapies Based Market Analysis, by Disorder, 2013-2022 ($MN)
Table 210 RoW RNA Based Therapies Based Market Analysis, by Target, 2013-2022 ($MN)
Table 211 RoW Monoclonal Antibodies (MAbs) Market Analysis, by Country, 2013-2022 ($MN)
Table 212 RoW Monoclonal Antibodies (MAbs) Market Analysis, by Molecule, 2013-2022 ($MN)
Table 213 RoW Monoclonal Antibodies (MAbs) Market Analysis, by Disorder, 2013-2022 ($MN)
Table 214 RoW Monoclonal Antibodies (MAbs) Market Analysis, by Target, 2013-2022 ($MN)
Table 215 RoW Phytotherapy Based Market Analysis, by Country, 2013-2022 ($MN)
Table 216 RoW Phytotherapy Based Market Analysis, by Molecule, 2013-2022 ($MN)
Table 217 RoW Phytotherapy Based Market Analysis, by Disorder, 2013-2022 ($MN)
Table 218 RoW Phytotherapy Based Market Analysis, by Target, 2013-2022 ($MN)
Table 219 RoW Pancreatic Beta-Cell Protection Market Analysis, by Molecule, 2013-2022 ($MN)
Table 220 RoW Small Molecules Market Analysis, by Country, 2013-2022 ($MN)
Table 221 RoW Small Molecules Market Analysis, by Therapy, 2013-2022 ($MN)
Table 222 RoW Small Molecules Market Analysis, by Disorder, 2013-2022 ($MN)
Table 223 RoW Small Molecules Market Analysis, by Target, 2013-2022 ($MN)
Table 224 RoW Large Molecules Market Analysis, by Country, 2013-2022 ($MN)
Table 225 RoW Large Molecules Market Analysis, by Therapy, 2013-2022 ($MN)
Table 226 RoW Large Molecules Market Analysis, by Disorder, 2013-2022 ($MN)
Table 227 RoW Large Molecules Market Analysis, by Target, 2013-2022 ($MN)
Table 228 RoW Pancreatic Beta-Cell Protection Market Analysis, by Disorder, 2013-2022 ($MN)
Table 229 RoW Type-1 diabetes Market Analysis, by Country, 2013-2022 ($MN)
Table 230 RoW Type-1 diabetes Market Analysis, by Therapy, 2013-2022 ($MN)
Table 231 RoW Type-1 diabetes Market Analysis, by Molecule, 2013-2022 ($MN)
Table 232 RoW Type-1 diabetes Market Analysis, by Target, 2013-2022 ($MN)
Table 233 RoW Type-2 diabetes Market Analysis, by Country, 2013-2022 ($MN)
Table 234 RoW Type-2 diabetes Market Analysis, by Therapy, 2013-2022 ($MN)
Table 235 RoW Type-2 diabetes Market Analysis, by Molecule, 2013-2022 ($MN)
Table 236 RoW Type-2 diabetes Market Analysis, by Target, 2013-2022 ($MN)
Table 237 RoW Pancreatic Beta-Cell Protection Market Analysis, by Target, 2013-2022 ($MN)
Table 238 RoW Beta Cell Apoptosis Market Analysis, by Country, 2013-2022 ($MN)
Table 239 RoW Beta Cell Apoptosis Market Analysis, by Therapy, 2013-2022 ($MN)
Table 240 RoW Beta Cell Apoptosis Market Analysis, by Molecule, 2013-2022 ($MN)
Table 241 RoW Beta Cell Apoptosis Market Analysis, by Disorder, 2013-2022 ($MN)
Table 242 RoW Other Targets Market Analysis, by Country, 2013-2022 ($MN)
Table 243 RoW Other Targets Market Analysis, by Therapy, 2013-2022 ($MN)
Table 244 RoW Other Targets Market Analysis, by Molecule, 2013-2022 ($MN)
Table 245 RoW Other Targets Market Analysis, by Disorder, 2013-2022 ($MN)

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report